Artwork

Content provided by Philip and Philip James. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Philip and Philip James or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Treating Graves' Disease with Ablation: New Perspectives from Dr. Alireza Falahati

1:03
 
Share
 

Manage episode 407405071 series 3560707
Content provided by Philip and Philip James. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Philip and Philip James or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In a recent interview with Philip James, host of the Doctor Thyroid and RFAMD podcasts, Dr. Alireza Falahati, a renowned endocrinologist from Utah, provided exciting insights from the TNT conference held in Reggio Emilia, Italy. The primary focus of the conversation was a groundbreaking development in the treatment of Graves' disease: the possibility of treating the entire thyroid gland with radiofrequency ablation (RFA), a potential game-changer in the management of this condition.

Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones, also known as hyperthyroidism. The conventional treatment strategies for Graves' disease include antithyroid medications, radioactive iodine therapy, and thyroid surgery. While effective, these treatments often come with potential side effects and risks, which highlights the need for novel, less invasive treatment options.

Radiofrequency ablation involves using heat generated from high-frequency alternating currents to ablate or destroy abnormal tissue. This technique has found applications in the treatment of various medical conditions, including certain types of cancers. Dr. Falahati's revelation about the potential use of RFA to treat the entire thyroid gland could significantly transform the therapeutic landscape for Graves' disease, offering a non-invasive and low-risk treatment alternative.

During the interview, Dr. Falahati expressed his enthusiasm about this novel approach, stating, "this is a new revelation. It is amazing. It's going to be really a game-changer and change our whole approach to patients with Graves' disease." The possibility of using RFA for the treatment of Graves' disease carries the promise of enhancing the quality of life for patients and instilling new hope for better disease management.

Dr. Falahati also stressed the value of scientific conferences like TNT, where experts worldwide convene to share knowledge and foster innovative discussions. He lauded the conference for facilitating learning experiences and supporting the growth of transformative treatment approaches.

As this method's adoption is still in the early stages, it's yet to be seen how quickly it will become a mainstream treatment option for Graves' disease. However, the optimism and anticipation echoed by Dr. Falahati signify a promising future in the field of endocrinology.

In conclusion, Dr. Falahati expressed his gratitude towards the organizers and participants of the TNT conference, highlighting his eagerness to attend next year's event. The insights gained from such platforms continually contribute to the advancement of medical science, paving the way for more effective, less invasive treatments for complex diseases like Graves'. Radiofrequency ablation promises to be a groundbreaking addition to the therapeutic options, potentially revolutionizing patient care and improving their quality of life.

View Dr. Alireza Falahati's Full Profile: https://www.rfamd.com/Alireza-Falahati/

🔷🔷🔷🔷The Doctor Thyroid and RFAMD podcast with Philip James is listened to in 100+ countries. It is a preferred patient resource for information related to thyroid cancer, RFA, hypothyroidism, pathology, and radiation therapy.

Contact Philip atphilipjames@docthyroid.com

www.rfamd.com www.docthyroid.com

About Philip James

He is the host of the popular podcast: Doctor Thyroidwww.docthyroid.com

In 2013, his laryngeal nerve was severed, shoulder nerve damaged, parathyroids ruined, and residual cancer left behind — all for a 1 cm thyroid nodule.Later, a vocal cord implant was inserted to help him speak.

100+ episodes later, the Doctor Thyroid podcast is popular amongst patients; allowing them to access information from top doctors, without being limited by geography or economics.

The word he uses to describe his work as patient advocate is, ‘tonglen’. Or, using his pain and hardship to help others.

The Doctor Thyroid podcast is available in Spanish and English – and listened to in over 30 countries:

www.doctiroides.com (Spanish)

www.docthyroid.com (English)

Please email your requests to philip@philipjames.co

Instagram: @PhilipJames360

LinkedIn: www.linkedin.com/in/philip-james/

Facebook: @philipb07

YouTube: @Doctor Thyroid Twitter : @docthyroid

  continue reading

34 episodes

Artwork
iconShare
 
Manage episode 407405071 series 3560707
Content provided by Philip and Philip James. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Philip and Philip James or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In a recent interview with Philip James, host of the Doctor Thyroid and RFAMD podcasts, Dr. Alireza Falahati, a renowned endocrinologist from Utah, provided exciting insights from the TNT conference held in Reggio Emilia, Italy. The primary focus of the conversation was a groundbreaking development in the treatment of Graves' disease: the possibility of treating the entire thyroid gland with radiofrequency ablation (RFA), a potential game-changer in the management of this condition.

Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones, also known as hyperthyroidism. The conventional treatment strategies for Graves' disease include antithyroid medications, radioactive iodine therapy, and thyroid surgery. While effective, these treatments often come with potential side effects and risks, which highlights the need for novel, less invasive treatment options.

Radiofrequency ablation involves using heat generated from high-frequency alternating currents to ablate or destroy abnormal tissue. This technique has found applications in the treatment of various medical conditions, including certain types of cancers. Dr. Falahati's revelation about the potential use of RFA to treat the entire thyroid gland could significantly transform the therapeutic landscape for Graves' disease, offering a non-invasive and low-risk treatment alternative.

During the interview, Dr. Falahati expressed his enthusiasm about this novel approach, stating, "this is a new revelation. It is amazing. It's going to be really a game-changer and change our whole approach to patients with Graves' disease." The possibility of using RFA for the treatment of Graves' disease carries the promise of enhancing the quality of life for patients and instilling new hope for better disease management.

Dr. Falahati also stressed the value of scientific conferences like TNT, where experts worldwide convene to share knowledge and foster innovative discussions. He lauded the conference for facilitating learning experiences and supporting the growth of transformative treatment approaches.

As this method's adoption is still in the early stages, it's yet to be seen how quickly it will become a mainstream treatment option for Graves' disease. However, the optimism and anticipation echoed by Dr. Falahati signify a promising future in the field of endocrinology.

In conclusion, Dr. Falahati expressed his gratitude towards the organizers and participants of the TNT conference, highlighting his eagerness to attend next year's event. The insights gained from such platforms continually contribute to the advancement of medical science, paving the way for more effective, less invasive treatments for complex diseases like Graves'. Radiofrequency ablation promises to be a groundbreaking addition to the therapeutic options, potentially revolutionizing patient care and improving their quality of life.

View Dr. Alireza Falahati's Full Profile: https://www.rfamd.com/Alireza-Falahati/

🔷🔷🔷🔷The Doctor Thyroid and RFAMD podcast with Philip James is listened to in 100+ countries. It is a preferred patient resource for information related to thyroid cancer, RFA, hypothyroidism, pathology, and radiation therapy.

Contact Philip atphilipjames@docthyroid.com

www.rfamd.com www.docthyroid.com

About Philip James

He is the host of the popular podcast: Doctor Thyroidwww.docthyroid.com

In 2013, his laryngeal nerve was severed, shoulder nerve damaged, parathyroids ruined, and residual cancer left behind — all for a 1 cm thyroid nodule.Later, a vocal cord implant was inserted to help him speak.

100+ episodes later, the Doctor Thyroid podcast is popular amongst patients; allowing them to access information from top doctors, without being limited by geography or economics.

The word he uses to describe his work as patient advocate is, ‘tonglen’. Or, using his pain and hardship to help others.

The Doctor Thyroid podcast is available in Spanish and English – and listened to in over 30 countries:

www.doctiroides.com (Spanish)

www.docthyroid.com (English)

Please email your requests to philip@philipjames.co

Instagram: @PhilipJames360

LinkedIn: www.linkedin.com/in/philip-james/

Facebook: @philipb07

YouTube: @Doctor Thyroid Twitter : @docthyroid

  continue reading

34 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide